This site is intended for healthcare professionals
Login
Register
Medical Education
Specialty
Drugs
News
Congresses
Search
Menu
Medical Education
Specialty
Drugs
News
Congresses
Home
/
Reading list
Your reading list
Find all your bookmarked pages here...
Share
Bookmarks
News
Fasenra (benralizumab) is approved in the European Union (EU) as an add-on treatment for adult patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis .- AstraZeneca
1 mins
News
Alnylam submits regulatory application to the European Medicines Agency for vutrisiran for the treatment of ATTR amyloidosis with cardiomyopathy
1 mins
Drug news
Oral Fabhalta (iptacopan) sustained clinically meaningful results at one year in Phase III C3 glomerulopathy (C3G) trial.- Novartis
3 mins
Industry news
Lyell Immunopharma to acquire ImmPACT Bio USA and with it IMPT 314
1 mins
Drug news
Pivotal VALIANT results presented at Kidney Week highlight strength of pegcetacoplan treatment effect in patients with C3G / Primary IC-MPGN- Sobi + Apellis
2 mins
Drug news
FDA approves Orlynvah (sulopenem etzadroxil and probenecid) for the treatment of uncomplicated urinary tract infections,- Iterum Therapeutics
1 mins
Industry news
AbbVie and Gedeon Richter tocollaborate on for the discovery and development of novel targets for neuropsychiatric conditions
1 mins
News
AbbVie and Gedeon Richter to collaborate on the discovery and development of novel targets for neuropsychiatric conditions
1 mins
Drug news
New SPECTREM study findings reveal Tremfya (guselkumab) effectively clears overlooked and undertreated plaque psoriasis- Johnson & Johnson
4 mins
Drug news
Dupixent late-breaking positive phase III data in chronic spontaneous urticaria to be presented at ACAAI- Sanofi
1 mins
Drug news
Darzalex (daratumumab-SC) based quadruplet regimen is approved by the European Commission for patients with newly diagnosed multiple myeloma who are transplant-eligible
1 mins
Industry news
Merck Inc., acquires Modifi Biosciences Inc.
1 mins
Drug news
FDA approval for Affera mapping and ablation system with Sphere-9 catheter for treatment of persistent atrial fibrillation
1 mins
Industry news
Bayer to licence a heart disease program from Dewpoint Therapeutics to treat dilated cardiomyopathy
1 mins
Drug news
TEAM-HF trial to measure pulmonary pressures using CardioMEMS HF System
3 mins
Drug news
Rigel Pharmaceuticals issues Dear Health Care Provider letter relating to Gavreto (pralsetinib)
1 mins
Drug news
FDA approves Keytruda (pembrolizumab) for endometrial carcinoma and FIGO 2014 Stage III-IVA cervical cancer
1 mins
Drug news
FDA approval for Abrysvo (respiratory syncytial virus vaccine), for prevention of LRTD caused by RSV in individuals 18 to 59 years
1 mins
Drug news
Successful outcome of interaction with FDA to deterime pathway for ST 920 (isaralgagene civaparvovec) for Fabry disease
1 mins
Drug news
FDA’s decision on the sNDA of sotorasib and panitumumab in KRAS G12C-mutated chemorefractory metastatic CRC has been delayed
1 mins
Drug news
Kisqali (ribociclib) recognized as Category 1 preferred breast cancer adjuvant treatment by NCCN Clinical Practice Guidelines in Oncology
1 mins
Drug news
NICE (UK) recommends Vanflyta (quizartinib ) to treat newly diagnosed FLT3‑ITD‑positive acute myeloid leukaemia
1 mins
Drug news
TerSera Therapeutics will acquire Margenza (margetuximab-cmkb) from MacroGenics
1 mins
Drug news
FDA approval for Farawave NAV Ablation Catheter for treatment of paroxysmal atrial fibrillation and for new Faraview Software
1 mins
Drug news
MHRA (UK) approves donanemab to treat mild cognitive impairment and mild dementia in the UK
1 mins
Drug news
NDA resubmitted to FDA for rivoceranib + camrelizumab as first-line systemic treatment for unresectable or metastatic hepatocellular carcinoma
1 mins
Drug news
FDA approval of additional presentation of Selarsdi (ustekinumab-aekn), expanding its label to include further indications
1 mins
Drug news
Headline results announced from the SOUL cardiovascular outcomes trial of oral semaglutide
1 mins
Drug news
Complete Response for CAM 2029 (octreotide) to treat acromegaly
1 mins
Drug news
CHMP positive for Yeslty (linzagolix) to treat endometrosis
1 mins
Drug news
CHMP positive for Tevimbra (tislelizumab) in gastric or gastroesophageal junction (G/GEJ) adenocarcinoma and esophageal squamous cell carcinoma (ESCC)
2 mins
Drug news
CHMP positive for Flucelvax vaccine to prevent influenza
1 mins
Drug news
Viatris obtains exclusive licence from Lexicon for sotaglifozin outside the US and EU.
1 mins
Drug news
CHMP positive for Kevzara (sarilumab) to treat polymyalgia rheumatica
1 mins
Drug news
FDA approves Botox Cosmetic (onabotulinumtoxinA) for temporary improvement in platysma bands in adults
2 mins
Drug news
Long-term efficacy and safety profile of Eylea 8 mg with extended dosing intervals in diabetic macular edema confirmed at three years
2 mins
Drug news
CHMP positive for Buprenorphine Neuraxpharm (buprenorphine) to treat opioid dependence
1 mins
Drug news
CHMP positive for Absimky (ustekinumab biosimilar) from Accord Healthcare/Intas
1 mins
Drug news
FDA approves Vyloy (zolbetuximab-clzb) + chemotherapy to treat EGFR receptor 2 (HER2)-negative gastric or gastroesophageal junction (GEJ) adenocarcinoma
1 mins
Drug news
CHMP positive for Fluad vaccine for the prevention of influenza disease in people áged 50 years and older
1 mins
Drug news
CHMP positive fro Korjuny (catumaxomab) for treatment of malignant ascites
1 mins
Drug news
CHMP positive for Alhemo (concizumab) as the first once-daily subcutaneous prophylactic treatment for people aged 12 years or older living with haemophilia A or B with inhibitors
1 mins
Drug news
The CHMP adopted a positive opinion for Wainzua (eplontersen) for the treatment of hereditary transthyretin-mediated amyloidosis and stage 1 or 2 polyneuropathy
1 mins
Drug news
CHMP positive for Siiltibcy for the diagnosis of Mycobacterium tuberculosis infection
1 mins
Drug news
Self-Amplifying mRNA COVID-19 vaccine demonstrates superior immune response compared with mRNA vaccine at 12 months post-vaccination- Seqirus/CSL
3 mins
Drug news
Gilead Sciences to withdraw Trodelvy (sacituzumab govitecan-hziy) for bladder cancer in the US.
1 mins
Drug news
CHMP opinion for Kisqali (ribociclib) to help reduce risk of recurrence in people with HR+/HER2- early breast cancer.- Novartis
1 mins
Drug news
NICE (UK) grants managed access to belzutifan to treat von Hippel-Lindau (VHL) disease
1 mins
Drug news
FDA approves the Versius Surgical System
1 mins
Drug news
New drug regimen funded by Cancer Care UK extends survival for cervical cancer patients
1 mins
Events
Event
GUF 2024
1 mins
Event
AARC Congress 2024
1 mins
Event
15th Biosimilars & Biologics Global Congress 2024 Europe
1 mins
Event
Reproductive Endocrinology 2024
1 mins
Event
WCPGHAN 2024 Congress
1 mins
Event
39th EACTAIC Annual Congress 2024
1 mins
Event
Kidney Week 2024
1 mins
You may be interested In
Journal
Long-term mortality after childhood growth hormone treatment: the SAGhE cohort study
1 mins
Journal
104-week efficacy and safety of cipaglucosidase alfa plus miglustat in adults with late-onset Pompe disease
1 mins
Journal
Home-based infusion of alglucosidase alfa can safely be implemented in adults with late-onset pompe disease: lessons learned from 18,380 infusions
1 mins
Journal
Advances in pompe disease treatment: from enzyme replacement to gene therapy
1 mins
Journal
Efficacy and safety of avalglucosidase alfa in patients with late-onset pompe disease after 97 weeks: a phase 3 randomized clinical trial
1 mins
Guideline
Start, switch and stop (triple-S) criteria for enzyme replacement therapy of late-onset Pompe disease: European Pompe Consortium recommendation update 2024
1 mins
Guideline
Diagnosis, genetics, and therapy of short stature in children: a Growth Hormone Research Society international perspective
1 mins
Guideline
AACE/ACE Guidelines for management of growth hormone deficiency in adults and patients transitioning from pediatric to adult care
1 mins
Guideline
BSPED recommendations for the use of once-weekly long-acting growth hormone therapy in children with growth hormone deficiency
1 mins
Guideline
Shared care guidelines for paediatric use of daily and long-acting recombinant human growth hormone
1 mins
Journal
Sex differences in long-term safety and tolerability of GH replacement therapy in GH deficient adults
1 mins
Top